The Nifty tumbled 1,164 points or 4.45% last week as the FIIs sold Nifty constituents for a slice of the dragon fruit. The Chinese CSI 300 that houses the top 200 stocks in Shanghai and the top 100 ... ( read original story ...)
Curator Of Wallace Chan’s Shanghai Exhibition Talks About The Artist
Wallace Chan’s latest exhibition at the newly opened Shanghai Museum East is also the largest and most encompassing to date with more than 200 of his creations in a space that properly represents his life’s work. The only unfortunate thing is that the three-month exhibition will end Monday (October 7). ( read original story ...)
Wong Kar-wai’s ‘Blossoms Shanghai,’ Coupang Play’s ‘Boyhood’ Take Top Prizes At Asia Contents Awards
Top prizes at Busan’s Asia Contents Awards & Global OTT Awards today went to Wong Kar-wai's first feature series Blossoms Shanghai and Coupang Play's Boyhood. Blossoms Shanghai won the Best Creative prize and the series’ Hu Ge won Best Lead Actor (Male). ( read original story ...)
Jannik Sinner overcomes slow start to advance at Shanghai Masters
Top-ranked Jannik Sinner overcame a one set deficit to rally to a 6-7 (3), 6-4, 6-2 win against Tomas Martin Etcheverry at the Shanghai Masters. ( read original story ...)
Wong Kar-wai’s ‘Blossoms Shanghai,’ Netflix’s ‘Cigarette Girl’ Win Top Prizes at Busan Streaming Awards
Wong Kar-wai's series debut “Blossoms Shanghai” won two of the top awards at the Busan International Film Festival‘s sixth annual Asia Contents Awards and Global OTT (streaming) Awards on Sunday. The Tencent Video Chinese series won best creative and best male lead actor for Hu Ge. ( read original story ...)
Daniil Medvedev Loses Cool in Abrupt Scenes as Insulting Chair Umpire Backfires Horribly at Shanghai Masters
Temperature is soaring high in Shanghai! The post Daniil Medvedev Loses Cool in Abrupt Scenes as Insulting Chair Umpire Backfires Horribly at Shanghai Masters appeared first on EssentiallySports. ( read original story ...)
Week In Review: Regor Sells 2 CDK Inhibitors To Genentech For $850m
Regor Pharma, a Shanghai-Boston biotech, sold global rights to Genentech for two early-stage CDK inhibitors aimed at breast cancer. Read more here. ( read original story ...)